SCP
HAE icon

Sivia Capital Partners’s Haemonetics HAE Stock Holding History

Sivia Capital Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$555K Sell
7,405
-985
-12% -$63.3K 0.07% 321
2026
Q1 		$473K Buy
8,390
+2,524
+43% +$164K 0.09% 268
2025
Q4 		$470K Buy
+5,866
New +$394K 0.1% 280
2025
Q3 		– Sell
-3,138
Closed -$234K – 491
2025
Q2 		$234K Buy
+3,138
New +$208K 0.08% 365

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sivia Capital Partners's HAE Position: Q2 2026 in Review

Sivia Capital Partners reduced its Haemonetics (HAE) stake by 12% in Q2 2026, selling an estimated $63.3K and leaving 7,405 shares worth $555K. The position accounts for 0.07% of the portfolio, ranked #321.

Sivia Capital Partners first reported a position in HAE in Q2 2025 and has held it in 4 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Sivia Capital Partners held 7,405 shares of Haemonetics worth $555K as of Q2 2026.
  • Sivia Capital Partners sold 985 Haemonetics shares in Q2 2026, an estimated $63.3K.
  • Haemonetics made up 0.07% of Sivia Capital Partners's portfolio in Q2 2026, its #321 holding.
  • Sivia Capital Partners first reported a position in Haemonetics in Q2 2025 and has held it in 4 quarters since.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.